UnitedHealth gained for a fourth day after approving a $2.21 dividend, sparking bullish sentiment and chatter about a possible Berkshire stake ahead of Thursday's 10-Q. Institutional buys from Renaissance Technologies and Chris Davis added momentum. Shares remain down 46% YTD but analysts mostly stay positive despite trimmed targets.